GBI - Pharmaceutical, Biotechnology & Device: Data, Intelligence, Consulting

2010年 9月 3日星期五

Chongqing health bureau on defensive as Qun Liu wins case
MOH to immunize 100 million children against measles
Three drug companies prosecuted for counterfeit VAT invoices
Insulin management at health centers launched in Beijing

2010年 9月 2日星期四

Yangtze River Pharma eyes TCM entry into the global market
Sinopharm signs joint venture agreement with Excelsior
Sanofi-aventis buys patent for anticancer drug developed in Shanghai
Sichuan: County levels to administer food and drug management

2010年 9月 1日星期三

Qingdao allocates RMB 700 million to biopharmaceutical park
Niusule Biotech signs distribution agreement with Nepstar

Andrew Webb, QIAGEN

http://www.gbipharma.com/podcast/mp3/GBI_Andrew_webb_interview.mp3

This month, Senior Director of Personalized Healthcare Market Development at QIAGEN, Andrew Webb, sits down with GBI to discuss the exciting field of personalized medicine. In this interview, Andrew offers an insider look at new applications for molecular targeting, as well as the role this technology will play in pharmaceutical development in the future.

Nisa Leung, Qiming Ventures

http://www.gbipharma.com/podcast/mp3/GBI_Nisa_Leung_interview.mp3

In this interview, Nisa Leung, partner of Qiming Ventures, shares her insights into how the venture capital landscape for the healthcare area has changed over the years, successful strategies for deal sourcing, and future trends in China’s healthcare market.